SGC0946 TFA
SGC0946 TFA is a selective inhibitor of DOT1L with an IC50 value of 0.3 nM. It induces G1 phase arrest in cancer cells by inhibiting DOT1L and reduces cellular self-renewal and metastatic potential while promoting cell differentiation. SGC0946 TFA is applicable in research for tumors such as leukemia and breast cancer and serves as a probe for studying the cellular mechanisms of DOT1L in both normal and diseased cells.
Product Specifications
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-351272A 1 g
6-amino-5- (chloroacetyl) -1-propylpyrimidine-2,4 (1H,3H) -dione
Sign In for Pricing
View Details 
MBS6277792-01 0.2 mL
BCAS2, NT (BCAS2, DAM1, Pre-mRNA-splicing factor SPF27, Breast carcinoma-amplified sequence 2, DNA amplified in mammary carcinoma 1 protein, Spliceosome-associated protein SPF 27) (Biotin)
Sign In for Pricing
View Details